Lydian Announces Third Quarter 2018 Results and Corporate Update

TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Lydian International Limited (TSX:LYD) ("Lydian" or the "Company") announced today its results for the three and nine months ended September 30, 2019. All dollar amounts referenced in this news release ar.....»»

TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Lydian International Limited (TSX:LYD) ("Lydian" or "the Company") announced today its results for the three and six months ended June 30, .....»»

Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients initiated in December 2018 First tRNA synthetase partnership announced in March 2019 SAN DIEGO, March .....»»

CORAL GABLES, Fla., March 18, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (NASDAQ:CPRX), a biopharmaceutical compa.....»»

Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update.....»»

Oraxol Phase III clinical trial in metastatic breast cancer fully enrolled Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting A numb.....»»

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update Phase 2b Results for Topical Ocular Reproxalap in Dry Eye Disease Expected in Late Third Quarter or Early Fourth Quarter 2018 Cli.....»»

Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update.....»»

BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update.....»»

- Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis .....»»

GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018......»»

CALGARY, Dec. 31, 2018 /CNW/.....»»

JERUSALEM, Feb. 27, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces financial results for the fourth quarter and year ended December 31.....»»

SEATTLE, May 14, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a cl.....»»

VBL Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update.....»»

aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19.....»»

Opiant Pharmaceuticals Announces First Quarter 2020 Financial Results and Corporate Update.....»»

Feraheme® (ferumoxytol injection) posts strong first quarter results Company implements a workforce reduction of approximately 30 percent or 140 positions, as part of a planned decrease in operating expenses Conference call scheduled fo.....»»

DENVER, May 04, 2020 (GLOBE NEWSWIRE) -- Vista Gold Corp. (TSX:VGZ) ("Vista" or the "Company") today announced its unaudited financial results for the quarter ended March 31, 2020. The Company's unaudited.....»»

MENLO PARK, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by.....»»